Cerapedics Gains $15M
Westminster, Colorado-based Cerapedics announced today that the firm has completed a Series B round of private equity financing, worth $15M. The round was led by NGN Capital, and also included prior investor OrbiMed Advisors. Cerapedics is developing medical devices for the osteobiologic market; the firm's products are a orthopedic bone graft substitute based on small peptide attachment factor technology. According to Cerapedics, NGN's Kenneth Abramowitz and Orbimed's Chau Khuong have joined its board along with the funding. Cerapedics said the funding will go towards sales and marketing of its products outside of the United States, as well as towards funding FDA clinical trials in the US. Techrockies first reported the funding last week.
posted on Monday, April 6, 2009 (Link to more information)
Related companies:
CeraPedics
Related stories:
> CeraPedics Raises $12.25M
> Cerapedics Gets $4M In Term Loan
> Cerapedics Raises $11M In Series D Funding
> Cerapedics Scores $22M For Bone Grafts
> Cerapedics Lands $19M Funding Round
Techrockies.com Home